To amend the Public Health Service Act to include neuropathy in the list of conditions covered by the World Trade Center Health Program, and for other purposes.

Bill 118 hr 2636, also known as the World Trade Center Health Program Expansion Act, aims to amend the Public Health Service Act to include neuropathy as a covered condition under the World Trade Center Health Program. This program was established to provide medical monitoring and treatment for individuals who were exposed to toxins and other hazards during the September 11, 2001 terrorist attacks in New York City.

Neuropathy is a condition that affects the nerves, causing symptoms such as numbness, tingling, and weakness in the affected areas. By including neuropathy in the list of covered conditions, individuals who are suffering from this condition as a result of their exposure to toxins at the World Trade Center site will now be eligible for medical care and treatment through the program.

In addition to expanding coverage to include neuropathy, the bill also includes provisions for other purposes related to the World Trade Center Health Program. This includes ensuring that individuals who were present at the World Trade Center site during the attacks are able to access the care and support they need to address any health issues that may have arisen as a result of their exposure. Overall, the World Trade Center Health Program Expansion Act seeks to provide much-needed support and resources to individuals who continue to suffer from health issues related to their exposure to toxins during the September 11 attacks. By including neuropathy as a covered condition and addressing other important issues, this bill aims to improve the health and well-being of those affected by this tragic event.